Keli L Hippen

8PUBLICATIONS
73CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K + Supramolecular Attack Particles.

|Jul 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease.

Lie Ma, Brent Koehn, Michael Zaiken

|Jul 21, 2025
A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD.

Danny W Bruce, Sonia J Laurie, Yan Xing

|Feb 07, 2025
Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance.

Brent H Koehn, Elizabeth C Nowak, Sladjana Skopelja-Gardner

|Feb 03, 2025
Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD.

Michael C Zaiken, Sujeong Jin, Cameron S McDonald-Hyman

|Dec 02, 2024
Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling.

Wenji Piao, Long Wu, Yanbao Xiong

Pageof 2

Frequent Collaborators

8 joint publications

Bruce R Blazar

4 joint publications

Michael C Zaiken

3 joint publications

Cindy R Eide

3 joint publications

Jakub Tolar